Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.03
Delayed Data
As of Feb 05
 -0.07 / -6.36%
Today’s Change
0.90
Today|||52-Week Range
3.42
-53.39%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.10
Today’s open1.09
Day’s range1.03 - 1.12
Volume377,387
Average volume (3 months)379,806
Market cap$124.1M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+4.76%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+26.59%
P/E ratioNM
Price/Sales4.54
Price/Book6.33

Competitors

 Today’s
change
Today’s
% change
NAVBNavidea Biopharmaceu...-0.02-2.44%
MNOVMediciNova Inc-0.14-3.26%
PRQRProQR Therapeutics N...-0.23-4.20%
DRNADicerna Pharmaceutic...-0.40-6.33%
Data as of 4:06pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.4M
Annual profit (last year)-$22.1M
Net profit margin-113.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts

Partner Offers